Conmed Corp Stock Price, News & Analysis

CONMED Corporation (NYSE: CNMD) will announce its financial results for Q1 2022 on April 27, 2022, after market close. A conference call will follow at 4:30 p.m. ET. Investors can join the call at 1-844-889-7792 (domestic) or +1-661-378-9936 (international) with passcode 9693807. The call will also be webcast on CONMED's website. A recording will be available from 7:30 p.m. ET on the same day until 7:30 p.m. ET on May 4, 2022.

CONMED Corporation (NYSE: CNMD) announced its Annual Meeting of Stockholders will take place virtually on May 25, 2022, at 1:30 p.m. ET. Shareholders on record as of April 5, 2022 can vote. Detailed participation instructions will be provided in the proxy statement to be filed on April 15, 2022, available on the company's website. CONMED specializes in surgical devices for minimally invasive procedures across various medical specialties.

CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, scheduled for payment on April 5, 2022. Shareholders on record as of March 15, 2022 will be eligible for this dividend. This decision underscores the company's commitment to returning value to its shareholders. CONMED specializes in medical technology, providing surgical devices for various specialties, which positions it well within the healthcare sector.

CONMED Corporation (NYSE: CNMD) reported a strong financial performance for Q4 and full year 2021. Q4 sales reached $274.0 million, an increase of 8.4% year-over-year. Domestic revenue rose 5.0% while international sales surged 12.7%. Q4 diluted EPS stood at $0.75, down from $0.81 in 2020, yet adjusted EPS rose to $1.07 from $0.84. For 2021, total sales hit $1.01 billion, a 17.2% increase. The company anticipates 2022 revenue of $1.075 billion to $1.125 billion and adjusted EPS between $3.60 and $3.85.

CONMED Corporation (NYSE: CNMD) will present at the 40th Annual J.P. Morgan Virtual Healthcare Conference on January 10, 2022, at 9:00 a.m. ET. The presentation will feature Curt R. Hartman, Chair of the Board, President & CEO, and Todd W. Garner, Executive Vice President and CFO. Investors can access a live webcast through the Company’s website, with a replay available afterward. CONMED is a medical technology company providing surgical devices for minimally invasive procedures across various specialties.

CONMED Corporation (NYSE:CNMD) will announce its fourth-quarter 2021 financial results after market close on January 26, 2022. The company's management will host a conference call at 4:30 p.m. ET the same day to discuss these results. Interested participants can join the call via phone or webcast through CONMED's website. A recording will be available for a week following the call. The company focuses on surgical devices for minimally invasive procedures across various medical specialties.

CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2022, to shareholders of record as of December 15, 2021. This decision highlights the company's commitment to returning value to its investors amidst ongoing challenges, including those posed by the COVID-19 pandemic and its impact on surgical procedures.

CONMED Corporation (NYSE: CNMD) has announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference. The pre-recorded fireside chat featuring Chair and CEO Curt R. Hartman and CFO Todd W. Garner will be available from 10:00 a.m. ET on November 22 until December 2, 2021, for registered attendees. Additionally, the chat can be replayed on the Company’s website starting November 22 at 10 a.m. ET. CONMED specializes in surgical devices for minimally invasive procedures across various medical specialties.

CONMED Corporation (NYSE: CNMD) announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 2:40 p.m. ET. A live webcast will be accessible via the company’s website. CONMED specializes in surgical devices for minimally invasive procedures across various medical specialties, including orthopedics and gastroenterology.